Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,867 | -6,737 | -3,102 | -14,660 | -10,835 |
| Depreciation Amortization | 176 | 117 | 58 | 230 | 149 |
| Accounts payable and accrued liabilities | -38 | -151 | -120 | 124 | 358 |
| Other Working Capital | 165 | -302 | -35 | 4,050 | 4,027 |
| Other Operating Activity | 1,783 | 1,608 | 530 | 1,026 | 146 |
| Operating Cash Flow | $-7,782 | $-5,465 | $-2,669 | $-9,230 | $-6,154 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31 | -31 | -9 | -250 | -148 |
| Investing Cash Flow | $-31 | $-31 | $-9 | $-250 | $-148 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 137 | 137 |
| Common Stock Issued | 9,254 | 6,372 | 6,372 | N/A | N/A |
| Other Financing Activity | -43 | -28 | -14 | -27 | -11 |
| Financing Cash Flow | $9,212 | $6,344 | $6,358 | $110 | $126 |
| Beginning Cash Position | 2,646 | 2,646 | 2,646 | 12,020 | 12,020 |
| End Cash Position | 4,044 | 3,494 | 6,326 | 2,640 | 5,844 |
| Net Cash Flow | $1,399 | $848 | $3,681 | $-9,370 | $-6,176 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,782 | -5,465 | -2,669 | -9,230 | -6,154 |
| Capital Expenditure | -31 | -31 | -9 | -255 | -148 |
| Free Cash Flow | -7,813 | -5,496 | -2,678 | -9,485 | -6,302 |